Resolve develops an automated platform that flags pricing discrepancies, coding mistakes, and billing errors in medical invoices, then deploys trained negotiators to secure fair rates or overturn insurance denials on behalf of patients. Leveraging proprietary data algorithms, the company has already eliminated nearly $20 million in medical debt, achieving average savings of 60–65 percent per bill. Founded in 2019 after CEO Braden Pan’s own experience with erroneous medical charges, Resolve now employs 22 full-time staff and plans to hire a Chief of Staff, Head of Product, and additional software developers. The business aims to scale its technology to address a share of the roughly $200 billion in U.S. medical debt. Recent seed financing strengthens the balance sheet and supports expansion of both engineering and advocacy teams. By combining data science with human expertise, Resolve positions itself as a leading medical-billing advocate focused on preventing everyday Americans from being bankrupted by healthcare costs.

Total raised

$3M

Funding rounds

1

Latest round

Seed

Latest activity

Jul 2022